Drug shortages have been such a critical industry issue recently that
it’s easy to overlook the good news: the IV solutions crisis is
definitely past its peak.
Congratulations to everyone in the healthcare
supply chain who worked many extra hours over the last many months to
ensure that products were available where they were needed most.
I had the opportunity today to attend a panel discussion on Capitol
Hill, hosted by B. Braun, focused on understanding the challenges
caused by recent IV fluid shortages and on alleviating future shortages.